Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry - Wikidata - wikimedia - TriplyDB

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry

http://www.wikidata.org/entity/Q57630914

about

Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure Hyponatremia Associated with Heart Failure: Pathological Role of Vasopressin-Dependent Impaired Water Excretion Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?Mild Chronic Hyponatremia in the Ambulatory Setting: Significance and Management Acute Heart Failure Registry: Risk Assessment Model in Decompensated Heart Failure Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?Factors associated with long-term mortality after Fontan procedures: a systematic review.Physiopathology, clinical diagnosis, and treatment of hyponatremia.Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure.Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy.Vasopressin antagonists for patients with acute heart failure: interpreting new clinical and translational data.Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study.Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients.Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.Preoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation.New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children Tolvaptan.Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure.Hyponatremia: A practical approach.Prognostic importance of hyponatremia in patients with acute pulmonary embolism.Clinical practice guideline on diagnosis and treatment of hyponatraemia.Prognostic significance of a multimarker strategy of biomarkers in acute heart failure.Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide Predictors of low cardiac output in decompensated severe heart failure.Tolvaptan, hyponatremia, and heart failure.Lower serum sodium level predicts higher risk of infection-related hospitalization in maintenance hemodialysis patients: an observational cohort study.Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis Hyponatraemia in Emergency Medical Admissions-Outcomes and Costs.Current treatment practice and outcomes. Report of the hyponatremia registry.Prognostic value of hyponatremia in heart failure patients: an analysis of the Clinical Characteristics and Outcomes in the Relation with Serum Sodium Level in Asian Patients Hospitalized for Heart Failure (COAST) study.Predictors of medication nonadherence differ among black and white patients with heart failure.Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure?Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension.A cross-sectional study of hyponatraemia among elderly patients with heart failure in Uganda.Heart failure in North America.Transient Hyponatremia During Hospitalization for Acute Heart Failure.Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].

P2860

Q26771172-1D97BE72-E3BD-4044-A64B-202913A23178 Q26799518-105519C8-3FFA-4184-97DD-74BD98B30247 Q28071921-EF1ED247-7F55-4B98-B706-0B72C3DB3D7D Q28082901-4D977DE1-9981-44FB-A044-AD314066E724 Q30100975-EE3B1DA2-1DB2-4D74-8D29-0D0B09C23AA4 Q30235394-89B6A5DE-083C-4E87-9E98-4016E150BE36 Q30239813-CB2BD681-CC83-4C73-8174-54BEDE08E4E2 Q30240732-595F52D1-1947-444B-9C1F-78164C23F69C Q30422457-B6652BF0-35D9-4119-807C-A76110E49C4E Q30432267-85652F43-EA33-420A-9873-2D7BCBD9D534 Q30717243-417385D2-7460-411A-AE88-4325A7B62F57 Q31121896-ECB0471E-DCDA-4FB3-AC33-12945CE70B25 Q33360986-6A433FF0-B390-4C90-826C-C133373A61EF Q33572449-052EA2CF-1847-4DC7-AA31-294485C79608 Q33712822-31DE0578-86AF-4518-ABDC-DEC24C319611 Q33818484-675CE515-2F09-4EFF-B19C-1BD4AFFBE403 Q33866957-80E0D991-BF14-4697-9D99-6EA405A7F5E7 Q34052281-42FCEF50-A65D-4EB5-8B10-61C5A3B1841A Q34305164-A0365B99-05AF-4EA8-8899-B11BB56BF7DA Q34319649-D72BC49D-E769-48BD-963E-DD59FBE40D03 Q34402419-4FE053D2-F8A8-4744-B908-430FB1A461E2 Q34406779-56894003-2F43-45D9-8DDE-75C77A054C19 Q34479808-8869FBEE-A287-4091-8808-980C70C02947 Q34570220-E7AE6800-454C-486F-BE3E-CD136DDFD4DF Q34643664-0801D1C2-2AD5-489F-8062-5716FC7470CE Q34691554-AE6F6DBC-1708-422C-B564-A7092E25882A Q35026759-DDC1477D-2235-475E-91AB-71C42251FA80 Q35071916-E7FD00E6-DBEC-47CF-B0AB-1D3DAC23D0A3 Q35075197-FA7B6AD7-1ED9-45DD-AB19-852CE984712B Q35750541-E0256C00-C08B-4089-BDB7-EC5C307DDA5B Q35814224-A85F3F26-F745-4E1B-9EC3-9061644CAB8B Q35834936-20EDAA9C-493B-4698-BD35-30CEC92E1579 Q35855340-E4A17276-DB70-4493-960C-E83B430EEFA9 Q36063303-BAF93C64-0AC1-4AF5-810E-F8E4F3826971 Q36578779-5F1686C9-E99C-4623-92F4-57354C4CF8C4 Q36718655-55CC8808-5950-41C9-B48F-A8EC882052C0 Q36920108-0DC77D0E-480B-4565-8A09-9B4DF139C92A Q36928519-E2895529-D834-4B8D-8714-009F752F9EB0 Q36932571-506A17B5-E017-4A14-B816-1BBCF13D930E Q36962261-759609CC-E412-4B90-85D9-B6CE3D61FD11

P2860

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry

http://www.wikidata.org/entity/Q57630914

description

article

@en

im April 2007 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2007

@uk

name

Relationship between admission ...... from the OPTIMIZE-HF registry

@en

Relationship between admission ...... from the OPTIMIZE-HF registry

@nl

type

label

Relationship between admission ...... from the OPTIMIZE-HF registry

@en

Relationship between admission ...... from the OPTIMIZE-HF registry

@nl

prefLabel

Relationship between admission ...... from the OPTIMIZE-HF registry

@en

Relationship between admission ...... from the OPTIMIZE-HF registry

@nl

P1433

Q57630914-0CC31D8D-FD38-4556-92BF-EFCD4321DC0D

P1476

Q57630914-5ACCD9A9-220B-4F77-90D7-9EB51A8B9111

P2093

Q57630914-0343B9C1-91C3-4563-9686-B35B317A5ACF

Q57630914-096EC123-2C11-4AAE-A4D5-3383F6DECCB8

Q57630914-112D999F-CE6D-4553-9400-19961AD22DD8

Q57630914-18AED387-3354-4CCB-8F32-C0E4652AC62E

Q57630914-5B725F14-4726-406E-B92A-E97DCB8EC914

Q57630914-68976C68-31A8-45C8-B560-B6E254108504

Q57630914-DA9568FC-ACB9-480D-813C-5AE5E4C8A53C

Q57630914-E2162AA4-CCEB-4E1D-87FD-D84A99BB9909

Q57630914-F23E531B-291A-4333-88BC-E8C31EA42E81

P304

Q57630914-17641141-8665-491C-8831-55D4477FAB34

P31

Q57630914-F57E96A9-8B24-4B5E-9CFF-DE22C0603A21

P356

Q57630914-523A9E80-365B-489C-8E13-041326D47B45

P433

Q57630914-7FEC883B-6979-463D-9674-7597B72CA9EF

P478

Q57630914-63D68703-1718-4D9C-9A9A-B6E1BC6DA264

P50

Q57630914-D3A21BB0-D2B5-431C-AEA5-1A2A61AC8F0D

P577

Q57630914-4DB8FF14-2C7E-4667-89C6-810277BE086C

P698

Q57630914-1400A806-6B6C-470B-8C5E-5605AD46083A

P921

Q57630914-8F0F61B1-6F53-41CD-8219-DF279932FD79

Q57630914-9DED983D-CE66-49E7-8BD2-E0F5F0965A95

P356

P1433

European Heart Journal

P1476

Relationship between admission ...... from the OPTIMIZE-HF registry

@en

P2093

B. H. Greenberg

http://www.w3.org/2001/XMLSchema#string

C. M. O'Connor

http://www.w3.org/2001/XMLSchema#string

G. C. Fonarow

http://www.w3.org/2001/XMLSchema#string

J. Young

http://www.w3.org/2001/XMLSchema#string

L. She

http://www.w3.org/2001/XMLSchema#string

M. Gheorghiade

http://www.w3.org/2001/XMLSchema#string

N. M. Albert

http://www.w3.org/2001/XMLSchema#string

W. Gattis Stough

http://www.w3.org/2001/XMLSchema#string

W. T. Abraham

http://www.w3.org/2001/XMLSchema#string

P304

980-988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHL542

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17309900

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization